MedTrace Logo

Monitoring of Arrhythmias in Patients Treated With Antipsychotics

NCT04575103 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 600

Last updated 2021-02-21

No results posted yet for this study

Summary

Antipsychotics may be associated to life-threatening arrhythmias and sudden cardiac death. This is the fist study to estimated the arrhythmic burden using long-term monitoring by implantable loop recorder in patients treated with antipsychotics.

Conditions

  • Death, Sudden, Cardiac
  • Arrythmia
  • Antipsychotics and Neuroleptics Toxicity

Interventions

DRUG

Antipsychotic

Antipsychotic treatment \>0.5 DDD

Sponsors & Collaborators

  • Rigshospitalet, Denmark

    collaborator OTHER

  • Bispebjerg Hospital

    collaborator OTHER

  • Nordsjaellands Hospital

    collaborator OTHER

  • University Hospital, Gentofte, Copenhagen

    collaborator OTHER

  • Zealand University Hospital

    collaborator OTHER

  • Odense University Hospital

    collaborator OTHER

  • Aarhus University Hospital

    collaborator OTHER

  • Aalborg University Hospital

    collaborator OTHER

  • Herlev and Gentofte Hospital

    lead OTHER

Principal Investigators

  • Casper Bang, MD, PhD · Department of Cardiology, Bispebjerg and Frederiksberg Hospital, Copenhagen University, Denmark

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-01-01
Primary Completion
2022-12-31
Completion
2024-12-31

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04575103 on ClinicalTrials.gov